Patent · US Active

Evolution of cytidine deaminases

US11913044B2 · kind B2 · utility

1Cited by
44References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 14, 2019
Grant dateFeb 27, 2024
Priority date
Expiry dateJun 14, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y305/04005
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Some aspects of this disclosure relate to strategies, systems, methods, compositions, and kits that are useful for production (e.g., evolution) of cytidine deaminase protein variants that are characterized by increased soluble expression and/or stability relative to the wild-type cytidine deaminase protein from which they are evolved. In some embodiments, evolved cytidine deaminase variants described by the disclosure are useful for incorporation into targeted nucleic acid editing proteins, for example in fusion proteins with a Cas9 domain or variant thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.